ArticleCell reports. Medicine2025

Disrupting AGR2/IGF1 paracrine and reciprocal signaling for pancreatic cancer therapy.

Hongzhen Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.